AKEBIA THERAPEUTIC earnings per share and revenue

AX9 earnings per share for the last quarter are -0.08 CHF whereas the estimation was -0.05 CHF which accounts for -57.90% surprise. Company revenue for the same period amounts to 31.72 M CHF despite the estimated figure of 37.71 M CHF. Estimated earnings per share for the next quarter are -0.07 CHF, and revenue is expected to reach 33.91 M CHF. Also watch annual changes over time to get a bigger picture of AX9 earnings per share and revenue dynamics.